Skip to content

Kevin Puylaert, Chief Sales Officer at SOPHiA GENETICS, sold SOPH on Jul 6, 2026

Data as of Oct 16

▼ SELL$693138 shares at $5.03Kevin Puylaert Chief Sales OfficerSOPH SOPHiA GENETICS SA
Watch SOPH
Traded
Jul 6, 2026
Disclosed
Jul 7, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Kevin Puylaert, Chief Sales Officer at SOPHiA GENETICS, sold SOPH on Jul 6, 2026TRADEDDISCLOSED
SOPHSimilar stocks (S&P 500 (SPY)), rebased to SOPH's price on the disclosure day
SOPH since disclosure
+23.7%
after the sale
Similar stocks (SPY) since disclosure
+2.1%
S&P 500 (SPY)

Change in closing price from Jul 7, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLKevin Puylaert Chief Sales OfficerSOPH SOPHiA GENETICS SA$158disclosed Jul 7 · filed 1 day after the trade
  2. ▼ SELLKevin Puylaert Chief Sales OfficerSOPH SOPHiA GENETICS SA$236disclosed Jul 7 · filed 1 day after the trade

See every trade on SOPH →